NIKKEI 225
39,695.76 +522.61 (+1.33%) HANG SENG
18,094.01 +21.11 (+0.12%) CRUDE OIL
81.04 +0.21 (+0.26%) GOLD FUTURES
2,328.90 -1.90 (-0.08%) DOW
39,112.16 -299.05 (-0.76%) Bitcoin GBP
49,020.91 +1,360.02 (+2.85%)
VNRX Oct 2024 2.500 put
| Previous close | 1.5500 |
| Open | N/A |
| Bid | 1.4000 |
| Ask | 2.1000 |
| Strike | 2.50 |
| Expiry date | 2024-10-18 |
| Day's range | 1.5500 - 1.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
PR NewswireVolitionRx Limited to Present at Jefferies Global Healthcare Conference
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynolds, President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City.
- GuruFocus.com
VolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...
Discover how VolitionRX Ltd is enhancing its financial structure and advancing key technologies for future growth.
PR NewswireVolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the first quarter of 2024. Volition management will host a conference call tomorrow, May 14 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.
